Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Dima, M. Kardara, H. Giannakopoulou, C. Roussos, N. Koulouris, N. Rovina (Athens, Greece). Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD). Eur Respir J 2013; 42: Suppl. 57, 395

Member's Comments

No comment yet.

Related content which might interest you: Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Eosinophilia as marker of outcome in hospitalised patients with AECOPD Source: Annual Congress 2013 –COPD and infections Year: 2013 COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 IL-17A is specifically elevated in NTHi-associated AECOPD and end-stage COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD) Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Pneumonic and non-pneumonic exacerbations of COPD: Systemic inflammatory response and clinical characteristics Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Recording and response to hyperglycaemia in patients presenting with infective exacerbations of COPD Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013